Current practices in the harmonisation of autoantibodies test.
10.3760/cma.j.cn112138-20220422-00298
- Author:
Ren Fang ZHOU
1
;
Min HE
2
;
Bin YANG
3
;
Xi LI
4
;
Chao Jun HU
5
Author Information
1. Department of Laboratory Medicine, Affiliated Wenling Hospital of Wenzhou Medical University, Taizhou 317500, China.
2. Department of Laboratory Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China.
3. Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu 610041, China.
4. Department of Laboratory Medicine, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
5. Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Autoantibodies;
Reference Standards
- From:
Chinese Journal of Internal Medicine
2023;62(4):356-362
- CountryChina
- Language:Chinese
-
Abstract:
Standardisation and harmonisation of the detection of autoantibodies is important for the clinical application of autoantibodies. However, achieving complete standardisation is difficult and involves several challenges due to the complexity and particularity of autoantibody detection. Harmonisation is feasible and valued, but it involves all aspects and processes of autoantibody detection. Based on the consensus and practice of the clinical application of autoantibody detection in recent years, we discuss harmonisation in this review.
